AION Healthspan, Inc. logo

AION Healthspan, Inc.

3 Marks
Corp.
First Filed:Sep 20, 2023Latest Filed:Jun 10, 2024Address:550 Bay Point Road, Miami, FL 33137

Portfolio Overview

Pending
3(100%)

Top Classes

Class 5
Pharmaceuticals
3(100%)
Class 1
Industrial Chemicals & Adhesives
3(100%)
Class 44
Medical, beauty and agricultural services
2(67%)

TTAB Proceedings

No litigation activity

Top Firms

Brown Rudnick LLP(Jun 2024)
2
Kilpatrick Townsend & Stockt...(Sep 2023)
1

Trademark Portfolio

3 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
AION HEALTHSPAN
AION HEALTHSPAN
Trademark
Combined
ITU
PENDING
Owner:
Serial:98594082
Filed:Jun 10, 2024
Classes:1, 5, 44
Goods & Services
Cells for medical, clinical, or veterinary use; Cell growth media for growing cells for medical or clinical use; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of inflammation; Pharmaceutical preparations for the treatment and prevention of chronic degenerative diseases; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Cells for scientific, laboratory or medical research; Cell growth media for growing cells for scientific and research use; Consulting services in the fields of health and nutrition; Providing health information in the field of age-related and chronic disease prevention and treatment; Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, including, bioidentical hormone replacement, anti aging therapy, and natural hormone therapy, medical aesthetic procedures, including, laser hair removal, laser peels, botulinum toxin treatments, microdermabrasion, liposuction, vein treatments, vein therapy, cellulite treatments, body contouring treatments, injectable filler treatments, facials, and skin care; "HEALTHSPAN"
AION HEALTHSPAN
AION HEALTHSPAN
Trademark
Word
ITU
PENDING
Owner:
Serial:98270496
Filed:Nov 14, 2023
Classes:1, 5
Goods & Services
Cells for medical, clinical, or veterinary use; Cell growth media for growing cells for medical or clinical use; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of inflammation; Pharmaceutical preparations for the treatment and prevention of chronic degenerative diseases; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Cells for scientific, laboratory or medical research; Cell growth media for growing cells for scientific and research use; "HEALTHSPAN"
REJUVXL
REJUVXL
Trademark
Word
ITU
PENDING
Owner:
Serial:98189228
Filed:Sep 20, 2023
Classes:1, 5, 42, +1
Goods & Services
Cell therapy preparation in the nature of cells for medical and clinical use; cell therapy preparation in the nature of cryopreserved cells for medical and clinical use; cell therapy preparation in the nature of cell suspension being living cells for medical and clinical use; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for injection for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells, for infusion for medical and clinical use for treating kidney disease; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for treating chronic diseases such as chronic kidney disease, inflammatory diseases such as lung disease, immune-mediated conditions such as autoimmune disease or graft-versus-host disease, degenerative diseases such as neurodegenerative diseases; cell therapy preparation in the nature of cell clusters being living cells clusters for medical and clinical use; cell therapy preparation in the nature of tissue being biological tissue cultures for medical and clinical use; therapeutic preparation in the nature of cell derivatives being biological materials derived from cells, namely extracellular vesicles, secretome, conditioned media, soluble factors, membrane fragments, or extracellular matrix for medical and clinical use; cell therapy preparation in the nature of pharmaceutical preparations comprised of molecules for combination with cell therapy for medical and clinical use for treating kidney disease; cell therapy preparation in the nature of pharmaceutical preparations comprised of molecules for combination with cells for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation in the nature of pharmaceutical preparations comprised of supramolecular complexes in combination with cells for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation of cell components being mitochondria or vesicles for medical and clinical use; Cell therapy preparation in the nature of cells for development use, other than for medical or veterinary purposes; Medical services; medical treatment using cultured cells; medical treatment of Chronic Kidney Disease using living cells; medical treatment, namely, injection of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment, namely, infusion of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment, namely, injection, infusion, and implantation of living cells in combination with induction and maintenance treatment with vitamins, protective molecules, and pharmacological agents for the treatment of Chronic Kidney Disease; Medical and scientific research and development in the field of cell therapy, regenerative medicine and healthspan medicine; cell therapy preparation in the nature of testing for research, development, engineering and testing services in the fields of immunopharmaceuticals, immunomodulators

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.